Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.

Join-Lambert O, Coignard H, Jais JP, Guet-Revillet H, Poirée S, Fraitag S, Jullien V, Ribadeau-Dumas F, Thèze J, Le Guern AS, Behillil S, Leflèche A, Berche P, Consigny PH, Lortholary O, Nassif X, Nassif A.

Dermatology. 2011 Feb;222(1):49-58. doi: 10.1159/000321716.

PMID:
21109728
2.

Second-line treatment for Helicobacter pylori infection based on moxifloxacin triple therapy: a randomized controlled trial.

Bago J, Pevec B, Tomić M, Marusić M, Bakula V, Bago P.

Wien Klin Wochenschr. 2009;121(1-2):47-52. doi: 10.1007/s00508-008-1122-2.

PMID:
19263014
3.

Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.

Mendonça CO, Griffiths CE.

Br J Dermatol. 2006 May;154(5):977-8.

PMID:
16634904
4.

Rifampicin and clindamycin for hidradenitis.

Wall D, Kirby B.

J Am Acad Dermatol. 2011 Apr;64(4):790. doi: 10.1016/j.jaad.2010.09.775. No abstract available.

PMID:
21414503
5.

Moxifloxacin is non-inferior to combination therapy with ceftriaxone plus metronidazole in patients with community-origin complicated intra-abdominal infections.

Solomkin J, Zhao YP, Ma EL, Chen MJ, Hampel B; DRAGON Study Team..

Int J Antimicrob Agents. 2009 Nov;34(5):439-45. doi: 10.1016/j.ijantimicag.2009.06.022.

PMID:
19692210
6.
8.

Moxifloxacin for bacterial keratitis.

Rosenberg J, Eisen L, Kim J.

Ophthalmology. 2008 Jun;115(6):1103; author reply 1103. doi: 10.1016/j.ophtha.2007.11.020. No abstract available.

PMID:
18519075
9.

Antibiotic Treatment of Hidradenitis Suppurativa.

Bettoli V, Join-Lambert O, Nassif A.

Dermatol Clin. 2016 Jan;34(1):81-9. doi: 10.1016/j.det.2015.08.013. Review.

PMID:
26617361
10.

Moxifloxacin in the treatment of acute bacterial rhinosinusitis: results of a multicenter, non-interventional study.

Zhou B, Jiang X, Zhai L, Xiao S, Wang J, Xiao G, Ruan B, Liang C, Ye Q, Hu B, Wang H.

Acta Otolaryngol. 2010 Sep;130(9):1058-64. doi: 10.3109/00016481003629036.

PMID:
20235900
11.

A randomized double-blind comparison of moxifloxacin and doxycycline/metronidazole/ciprofloxacin in the treatment of acute, uncomplicated pelvic inflammatory disease.

Heystek M, Ross JD; PID Study Group..

Int J STD AIDS. 2009 Oct;20(10):690-5. doi: 10.1258/ijsa.2008.008495.

PMID:
19815913
12.

Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens.

Hoeffken G, Talan D, Larsen LS, Peloquin S, Choudhri SH, Haverstock D, Jackson P, Church D.

Eur J Clin Microbiol Infect Dis. 2004 Oct;23(10):772-5.

PMID:
15605184
13.

Status epilepticus attributed to moxifloxacin in an adolescent patient with spina bifida occulta.

Qiao L, Cui X, Li Y.

Eur J Clin Pharmacol. 2011 Jan;67(1):103-4. doi: 10.1007/s00228-010-0887-1. No abstract available.

PMID:
20809082
14.

Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis.

Li Y, Huang X, Yao L, Shi R, Zhang G.

Wien Klin Wochenschr. 2010 Jul;122(13-14):413-22. doi: 10.1007/s00508-010-1404-3.

PMID:
20628905
15.

Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial.

Constantinou M, Daniell M, Snibson GR, Vu HT, Taylor HR.

Ophthalmology. 2007 Sep;114(9):1622-9.

PMID:
17822972
16.

Efficacy and safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study.

Judlin P, Liao Q, Liu Z, Reimnitz P, Hampel B, Arvis P.

BJOG. 2010 Nov;117(12):1475-84. doi: 10.1111/j.1471-0528.2010.02687.x.

17.

Moxifloxacin-induced hypoglycemia in a non-diabetic patient.

Mandavia DR, Virpariya MM, Patel TK, Tripathi CB.

Curr Drug Saf. 2012 Apr;7(2):183-5.

PMID:
22873504
18.

Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial.

Pelekanou A, Kanni T, Savva A, Mouktaroudi M, Raftogiannis M, Kotsaki A, Giamarellos-Bourboulis EJ.

Exp Dermatol. 2010 Jun;19(6):538-40. doi: 10.1111/j.1600-0625.2009.00967.x.

PMID:
19758320
19.

Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.

Gener G, Canoui-Poitrine F, Revuz JE, Faye O, Poli F, Gabison G, Pouget F, Viallette C, Wolkenstein P, Bastuji-Garin S.

Dermatology. 2009;219(2):148-54. doi: 10.1159/000228334.

20.

Electroconvulsive therapy and antibiotics: a case report.

Reti IM, Davydow DS.

J ECT. 2007 Dec;23(4):289-90.

PMID:
18090707

Supplemental Content

Support Center